Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total	Common Stock Outstanding	Common Stock	Value of Shares Held in Rabbi Trust at Cost	Deferred Compensation Obligation	Additional Paid in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022		$ 2,886,701		$ 455	$ (3,227)	$ 3,227	$ 2,114,888	$ 934,442	$ (163,084)
Beginning balance (in shares) at Dec. 31, 2022			45,641,238
Net income		239,502						239,502
Other comprehensive income		$ 48,257							48,257
Common Stock, Dividends, Per Share, Declared		$ 2.20
Common dividend declared		$ (96,456)						(96,456)
Common stock issued for acquisition		0
Proceeds from exercise of stock options, net of cash paid		81					81
Proceeds from exercise of stock options (in shares)			3,238
Stock based compensation		6,377					6,377
Restricted stock awards issued, net of awards surrendered (in shares)			82,181
Restricted stock awards issued, net of awards surrendered		(1,135)		1			(1,136)
Stock Issued During Period, Shares, Other			46,963
Stock Issued During Period, Value, Other		2,682					2,682
Stock Repurchased During Period, Shares			(2,900,433)
Stock Repurchased During Period, Value		(190,758)		(29)			(190,729)
Increase (Decrease) in Deferred Compensation					(71)	71
Ending balance (in shares) at Dec. 31, 2023			42,873,187
Ending balance at Dec. 31, 2023		2,895,251		427	(3,298)	3,298	1,932,163	1,077,488	(114,827)
Sales and Excise Tax Payable		1,800
Net income		192,081						192,081
Other comprehensive income		$ 24,820							24,820
Common Stock, Dividends, Per Share, Declared		$ 2.28
Common dividend declared		$ (96,845)						(96,845)
Common stock issued for acquisition		0
Proceeds from exercise of stock options, net of cash paid		81		0			81
Proceeds from exercise of stock options (in shares)			1,667
Stock based compensation		6,523					6,523
Restricted stock awards issued, net of awards surrendered (in shares)			99,692
Restricted stock awards issued, net of awards surrendered		(781)		1			(782)
Stock Issued During Period, Shares, Other			58,331
Stock Issued During Period, Value, Other		3,287					3,287
Stock Repurchased During Period, Shares			(532,266)
Stock Repurchased During Period, Value		(31,297)		(5)			(31,292)
Increase (Decrease) in Deferred Compensation		$ 0
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits					(85)	85
Ending balance (in shares) at Dec. 31, 2024		42,500,611	42,500,611
Ending balance at Dec. 31, 2024		$ 2,993,120		423	(3,383)	3,383	1,909,980	1,172,724	(90,007)
Sales and Excise Tax Payable		311
Net income		205,122						205,122
Other comprehensive income		$ 50,253							50,253
Common Stock, Dividends, Per Share, Declared		$ 2.36
Common dividend declared		$ (108,733)						(108,733)
Common stock issued for acquisition		477,266		75			477,191
Common stock issued for acquisition (in shares)			7,478,906
Proceeds from exercise of stock options (in shares)			380
Stock based compensation		8,985					8,985
Restricted stock awards issued, net of awards surrendered (in shares)			137,410
Restricted stock awards issued, net of awards surrendered		(1,403)		1			(1,404)
Stock Issued During Period, Shares, Other			39,364
Stock Issued During Period, Value, Other		2,575					2,575
Stock Repurchased During Period, Shares	[1]		(912,858)
Stock Repurchased During Period, Value	[1]	(61,457)		(9)			(61,448)
Increase (Decrease) in Deferred Compensation		$ 0
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits					(69)	69
Ending balance (in shares) at Dec. 31, 2025		49,243,813	49,243,813
Ending balance at Dec. 31, 2025		$ 3,565,728		$ 490	$ (3,452)	$ 3,452	$ 2,335,879	$ 1,269,113	$ (39,754)
Sales and Excise Tax Payable		$ 608

[1] Inclusive of $608,000, $311,000 and $1.8 million impact of excise tax attributable to shares repurchased under a repurchase program for the years ended December 31, 2025, 2024 and 2023, respectively.